Does NIROGACESTAT Cause Product distribution issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product distribution issue have been filed in association with NIROGACESTAT (OGSIVEO). This represents 1.0% of all adverse event reports for NIROGACESTAT.
5
Reports of Product distribution issue with NIROGACESTAT
1.0%
of all NIROGACESTAT reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product distribution issue From NIROGACESTAT?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIROGACESTAT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NIROGACESTAT Cause?
Diarrhoea (220)
Nausea (136)
Fatigue (110)
Headache (62)
Product dose omission issue (60)
Rash (59)
Vomiting (50)
Stomatitis (42)
Product dose omission in error (34)
Cough (33)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which NIROGACESTAT Alternatives Have Lower Product distribution issue Risk?
NIROGACESTAT vs NIROGACESTAT HYDROBROMIDE
NIROGACESTAT vs NIRSEVIMAB
NIROGACESTAT vs NIRSEVIMAB-ALIP
NIROGACESTAT vs NITAZOXANIDE
NIROGACESTAT vs NITISINONE